Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Omada Health (OMDA) Research & Development (2024 - 2025)

Omada Health (OMDA) has disclosed Research & Development for 2 consecutive years, with $11.6 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 25.7% to $11.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $41.1 million through Dec 2025, changed N/A year-over-year, with the annual reading at $40.7 million for FY2025, 13.25% up from the prior year.
  • Research & Development hit $11.6 million in Q4 2025 for Omada Health, up from $10.3 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $11.6 million in Q4 2025 to a low of $8.8 million in Q3 2024.